Have we cut ourselves too short in mapping CTL epitopes?
- 1 January 2006
- journal article
- Published by Elsevier BV in Trends in Immunology
- Vol. 27 (1), 11-16
- https://doi.org/10.1016/j.it.2005.11.001
Abstract
No abstract availableKeywords
This publication has 65 references indexed in Scilit:
- T cell receptor recognition of a 'super-bulged' major histocompatibility complex class I–bound peptideNature Immunology, 2005
- Agonist/endogenous peptide–MHC heterodimers drive T cell activation and sensitivityNature, 2005
- Potent T cell response to a class I‐binding 13‐mer viral epitope and the influence of HLA micropolymorphism in controlling epitope lengthEuropean Journal of Immunology, 2004
- Strategic Mutations in the Class I Major Histocompatibility Complex HLA-A2 Independently Affect Both Peptide Binding and T Cell Receptor RecognitionPublished by Elsevier BV ,2004
- Direct observation of ligand recognition by T cellsNature, 2002
- Identification of a Crucial Energetic Footprint on the α1 Helix of Human Histocompatibility Leukocyte Antigen (Hla)-A2 That Provides Functional Interactions for Recognition by Tax Peptide/Hla-A2–Specific T Cell ReceptorsThe Journal of Experimental Medicine, 2001
- Getting into the groove: unusual features of peptide binding to MHC class I molecules and implications in vaccine designFrontiers in Bioscience-Landmark, 2001
- Preferential expression of TCR Vα regions in CD4/CD8 subsets: class discrimination or co-receptor recognition?Immunology Today, 1998
- Determinant selection of major histocompatibility complex class I-restricted antigenic peptides is explained by class I-peptide affinity and is strongly influenced by nondominant anchor residues.The Journal of Experimental Medicine, 1994
- Existence of a molecular ruler in proteasomes suggested by analysis of degradation productsFEBS Letters, 1994